Epstein Secrets

2015 EVONIK INDUSTRIES At its meeting in December, the Supervisory Board discussed the Declaration of Conformity in compliance with Section 161 of the German Stock Corporation Act (AktG), the budget for 2016, the mid-term planning for the period to 2018, and progress in implementing the measures adopted following the efficien

oser. • Finance and Investment Committee: Michael Radiger (Chairman), Michael Vassiliadis (Deputy Chairman), Gunter Adam (until December 10, 2015), Martin Albers (from December 11, 2015), Stephan Gemkow, Ralf Hermann, Frank Lallgen, Dr. Werner Muller and Dr. Christian Wildmoser. • Nomination Committee: Dr. W

Section 315 Paragraph 4 of the German Com- mercial Code (HGB) and explanatory report by the Executive Board pursuant to Section 176 Paragraph 1 of the German Stock Corporation Act (AktG) Structure of issued capital The capital stock of Evonik Industries AG is €466,000,000 and is divided into 466,000,000 no-par registered sha

e Attendance fees Total In C000 2015 2014 2015 2014 2015 2014 2015 2014 GOnter Adam (until December 10, 2015) 58 58 10 10 158 158 Martin Albers (from October 1, 2015) 23 2 26 Prof. Barbara Albert (from July 1, 2014) 45 95 47 Dr. peter Bettermann (until June 30, 2014) 45 - I 48

boards. b) Membership of comparable German and foreign supervisory bodies of business enterprises pursuant to Section 125 Paragraph 1 Sentence 5 of the German Stock Corporation Act (AMC). EFTA00598848 216 FINANCIAL REPORT 2015 EVONIK INDUSTRIES Executive Board of Evonik Industries AG Dr. Klaus Engel, Mulheirn an der Ruhr

Chemical and Energy Industrial Union (IG BCE) a) BASF SE K+S AG RAG Aktiengesellschaft RAG Deutsche Steinkohle AG STEAG GmbH b) RAG-Stiftung Martin Albers, Dorsten (since October 1,2015) Deputy Chairman of the Works Council for the Essen Campus facilities a) Pensionskasse Degussa VVaG b) PEAG Holdi